Fundraising Fox
/Companies
Sign in

Glycotest

Merion Station, US · Delaware corporation · 2 known investors

Find your way into Glycotest

Each arrow is one introduction. Sign up to fill in the first one.

3 people can intro you to Charles

Ask Vijay Barathan to introduce you to Charles Swindell

You →Vijay · together at NetScientific PLC →Charles

Sign up to find every way you can get introduced to Glycotest

  • Your email: who you already know at Glycotest, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Glycotest team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer. The company operates in the biomedical diagnostics field within the healthcare industry.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

CSCharles Swindell
Charles SwindellExecutiveCharles Swindell is Executive Officer and Director at Glycotest, a biomedical diagnostics company developing tests for early detection of liver disease and liver cancer. He brings over 20 years of experience in life sciences across diagnostics, biomarkers, and therapeutics in startup and established commercial-stage companies.

Board

IIIlian Iliev
Ilian IlievBoard directorChief Executive Officer at EMV Capital
EHEd Hooper
Ed HooperBoard directorExecutive Director at EMV Capital
JJ
Jenny JiangBoard director

Investors · 2

EMV Capitallisted by EMV CapitalLondon

How we know: EMV Capital's portfolio page · offering press articles · funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$3.2M disclosed across 1 of 2 rounds · 2018–2026

▶$3.2MraisedJul 2026 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles SwindellExecutive Officer, Director
  • Ilian IlievDirector
  • Ed HooperDirector
  • Jenny JiangDirector
Offering amount
$6.8M
Amount sold
$3.2M
Sales commissions
$77.4K
Placement agents
EMV Capital Partners
First sale
Jun 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Glycotest Inc. Closes $10 Million Series A Financing - BioSpacebiospace.com · Oct 2018

Frequently asked questions

What does Glycotest do?
Glycotest develops diagnostic tests for the early detection of liver disease and liver cancer. The company operates in the biomedical diagnostics field within the healthcare industry.
Who are Glycotest's investors?
Glycotest's investors include Fosun Pharma, EMV Capital.
How much funding has Glycotest raised?
Glycotest has disclosed $3.2M raised across 1 of its 2 known rounds.
Where is Glycotest headquartered?
Glycotest is headquartered in Merion Station, US.